NAVIGATION
 
> Home
> OPPI Vision
> OPPI Mission
> Office Bearers 
> Committees
> News and Events
> OPPI Position on IPR
> Pharma Spectrum - Monthly News At A Glance
> Pharma Spectrum 2010 - News at a glance
> Pharma Spectrum 2009 - Year at a glance
> Pharma Spectrum 2008 - Year at a glance
> OPPI Position on Biosimilars
> OPPI Position on Data Protection
> OPPI Anti - Counterfeiting Guidelines
> A Handy Guide for Road Safety
> A OPPI IPR Symposium Videos
> Patents
> Drug Policy & Pricing
> Regulatory
> Links
> India OTC Pharmaceutical Profile 2010
> Important Government Notifications
   
 

 

IFPMA Clinical
Trials Portal

IFPMA - Improving
Global Health


OPPI Code on
Conduct of
Clinical Trials


OPPI - YES Bank Report,
Pharmaceutical Industry:
Vision 2015


OPPI IPR
Symposium Proceedings

 




About Us Members Publications Contact Us
 
  OPPI NEWS
 

DoP Plans Major Projects to Boost Pharma Manufacturing, R&D and Medical Devices Sector
August 11, 2009, Pharmabiz


The Central government, through the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilisers, is contemplating major projects including establishment of two pharma clusters, a pharma city, a vaccine development centre and four R&D hubs in the country to augment the manufacturing and R&D capacity of the Indian pharmaceutical sector. As the first phase of the proposed Pharma India Vision 2020, which emphasises on developing adequate infrastructure to support the expected growth in the India pharma industry, the department will set up a Pharma City in Andhra Pradesh. The DoP is in talks with the Andhra Pradesh Industrial Infrastructure Corporation to develop an 800 to 900 acre cluster in Hyderabad, said Ashok Kumar, secretary, DoP on the sidelines of the 43rd Annual General Meeting of Organisation of Pharmaceutical Producers of India (OPPI) in Mumbai.



            Copyright © 2008. Organisation of Pharmaceutical Producers of India. All Rights Reserved.  |   Disclaimer  |